Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial.

Autor: Cesne, Axel Le1, Blay, Jean-Yves2, Domont, Julien1, Tresch-Bruneel, Emmanuelle3, Chevreau, Christine4, Bertucci, François5, Delcambre, Corinne6, Saada-Bouzid, Esma7, Piperno-Neumann, Sophie8, Bay, Jacques-Olivier5, Mir, Olivier1, Ray-Coquard, Isabelle2, Ryckewaert, Thomas9, Valentin, Thibaud4, Isambert, Nicolas10, Italiano, Antoine11, Clisant, Stéphanie12,13, Penel, Nicolas9,13 n-penel@o-lambret.fr
Zdroj: Lancet Oncology. Mar2015, Vol. 16 Issue 3, p312-319. 8p.
Databáze: Academic Search Ultimate